Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients-Reference-Cited by-同舟云学术

Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients

Published:2021-11-30 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

AlZaabi Adhari,AlAmri Hafsa,ALAjmi Ghadeer,Allawati Manhal,Muhanna Fatema,Alabri Ruqaia,AlBusaidi Fatema,AlGhafri Shaima,Al-Mirza Abdulrahman A,Al Baimani Khalid

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference29 articles.

1. Molecular mechanisms of tamoxifen-associated endometrial cancer (Review);Hu R;Oncol Lett,2015

2. Tamoxifen: the herald of a new era of preventive therapeutics;Jordan CV;J Natl Cancer Inst,1997

3. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies C;Lancet,2011

4. Tamoxifen for women at high risk of breast cancer;Nazarali SA;Breast Cancer (Dove Med Press),2014

5. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer;Bergman L;Lancet,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning-Based Nomogram for Predicting Endometrial Lesions after Tamoxifen Therapy in Breast Cancer Patients;2024-08-13

2. Roles of estrogen receptor α in endometrial carcinoma (Review);Oncology Letters;2023-10-25

3. Ultrasonic presentation variation of patients with pathological evidence of endometrial atrophy;Taiwanese Journal of Obstetrics and Gynecology;2023-09

4. An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management;Journal of Personalized Medicine;2023-04-28